Fig. 1From: Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysisStudy selection process according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guideline. After evaluating the total of 595 studies, 74 studies met the eligibility criteria and used in qualitative and quantitative analysesBack to article page